These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 34984723

  • 1. Bone mineral density, bone metabolism-related factors, and microRNA-218 are correlated with disease activities in Chinese ankylosing spondylitis patients.
    Liu J, Zhao L, Yang X, Liu C, Kong N, Yu Y, Xuan D, Wan W, Xue Y.
    J Clin Lab Anal; 2022 Feb; 36(2):e24223. PubMed ID: 34984723
    [Abstract] [Full Text] [Related]

  • 2. [The value of researches, which assess bone mineral density and bone metabolism in patients with ankylosing spondylitis, in detecting osteoporosis].
    Przepiera-Bedzak H.
    Ann Acad Med Stetin; 2007 Feb; 53(3):39-47. PubMed ID: 18595484
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
    Taylan A, Sari I, Akinci B, Bilge S, Kozaci D, Akar S, Colak A, Yalcin H, Gunay N, Akkoc N.
    BMC Musculoskelet Disord; 2012 Oct 02; 13():191. PubMed ID: 23025387
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
    Kim HR, Lee SH, Kim HY.
    Rheumatology (Oxford); 2006 Oct 02; 45(10):1197-200. PubMed ID: 16567356
    [Abstract] [Full Text] [Related]

  • 5. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
    Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, Váncsa A, Bodnár N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhász B, Nagy Z, Hodosi K, Karosi T, FitzGerald O, Szücs G, Szekanecz Z, Szamosi S, Szántó S.
    Clin Rheumatol; 2020 Jan 02; 39(1):167-175. PubMed ID: 31522318
    [Abstract] [Full Text] [Related]

  • 6. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
    Grazio S, Kusić Z, Cvijetić S, Grubišić F, Balenović A, Nemčić T, Matijević-Mikelić V, Punda M, Sieper J.
    Rheumatol Int; 2012 Sep 02; 32(9):2801-8. PubMed ID: 21858541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.
    van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA, van der Horst-Bruinsma IE.
    Clin Rheumatol; 2012 Nov 02; 31(11):1529-35. PubMed ID: 22706444
    [Abstract] [Full Text] [Related]

  • 9. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H.
    J Rheumatol; 2014 Jul 02; 41(7):1349-56. PubMed ID: 24931960
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis.
    Ulu MA, Batmaz İ, Dilek B, Çevik R.
    Chin Med J (Engl); 2014 Jul 02; 127(15):2740-7. PubMed ID: 25146606
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis.
    Bao J, Chen Y, Bao YX.
    Calcif Tissue Int; 2014 Aug 02; 95(2):108-11. PubMed ID: 24854154
    [Abstract] [Full Text] [Related]

  • 12. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    Kaya A, Ozgocmen S, Kamanli A, Ardicoglu O.
    Med Princ Pract; 2009 Aug 02; 18(6):470-6. PubMed ID: 19797924
    [Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Torres L, Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H.
    Osteoporos Int; 2019 Feb 02; 30(2):441-449. PubMed ID: 30306221
    [Abstract] [Full Text] [Related]

  • 14. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis.
    Toussirot E, Michel F, Wendling D.
    Rheumatology (Oxford); 2001 Aug 02; 40(8):882-8. PubMed ID: 11511757
    [Abstract] [Full Text] [Related]

  • 15. Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis.
    Incel NA, Gökoğlu F, Nacir B, Incel N.
    Clin Rheumatol; 2006 Sep 02; 25(5):667-70. PubMed ID: 16333564
    [Abstract] [Full Text] [Related]

  • 16. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study.
    Magrey MN, Lewis S, Asim Khan M.
    Semin Arthritis Rheum; 2016 Aug 02; 46(1):88-94. PubMed ID: 27162010
    [Abstract] [Full Text] [Related]

  • 17. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis.
    Kim JW, Chung MK, Lee J, Kwok SK, Kim WU, Park SH, Ju JH.
    Clin Rheumatol; 2019 Dec 02; 38(12):3567-3574. PubMed ID: 31402392
    [Abstract] [Full Text] [Related]

  • 18. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density.
    Mitra D, Elvins DM, Speden DJ, Collins AJ.
    Rheumatology (Oxford); 2000 Jan 02; 39(1):85-9. PubMed ID: 10662879
    [Abstract] [Full Text] [Related]

  • 19. Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis.
    Wu X, Zhong JY, Wang G, Xu HJ.
    Chin Med J (Engl); 2021 Oct 13; 134(21):2556-2563. PubMed ID: 34653076
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.